Copyright
©The Author(s) 2015.
World J Orthop. Dec 18, 2015; 6(11): 919-926
Published online Dec 18, 2015. doi: 10.5312/wjo.v6.i11.919
Published online Dec 18, 2015. doi: 10.5312/wjo.v6.i11.919
Table 2 Large case series of total femoral replacement in current literature
Ref. | Publication | n | Age | Indications | Follow-up (mo) | Patients living at time of publication | Survivorship | All-cause revision rate | Complications | Prosthesis used |
Ahmed[28] | Arch Orthop Trauma Surg | 9 | 47 (10-74) | Oncologic | 51 (8-200) | 4/9 | No failures | 0% | Infection (2), tibial component loosening (1) | Zimmer |
Amanatullah et al[3] | J Arthroplasty | 20 | 65 ± 11 | Non-oncologic (revision arthroplasty) | 73 ± 49 | 0/20 | 70% at 5 yr follow-up | 30% | Infection (7), hip dislocation (5), limb length discrepancy (2), knee flexion contracture (1) | Biomet, Link Stryker |
Berend et al[2] | Clin Orthop Relat Res | 59 | 74 (39-91) | Non-oncologic (end-stage prosthetic disease) | 58 (12-156) | 14/59 | 65% at 5 yr follow-up | 30.5% | Infection (8), hip dislocation (7), tibial component loosening (2), acetabular component loosening (1) | Biomet, Link |
Fountain et al[10] | J Arthroplasty | 14 | 63.7 (48-79) | Non-oncologic (revision arthroplasty) | 90 (12-204) | 13/14 | NA | 35.7% | Hip dislocation (5), infection (3) | Link |
Friesecke et al[30] | J Bone Joint Surg Am | 100 | 68 (40-94) | Non-oncologic (revision arthroplasty) | 59 (1-138) | 95/100 | NA | 21% | Infection (12), hip dislocation (6), prosthesis failure (3), patellar issues (2), hematoma (2), peroneal nerve palsy (1), delayed wound healing (1) | Link |
Lombardi et al[12] | J Arthroplasty | 75 | 73 (36-92) | Non-oncologic (end-stage prosthetic disease) | 42 (1-158) | 50/75 | NA | 30.7% | Infection (11), hip dislocation (7), tibial component loosening (2), acetabular component loosening (1), hematoma (1), periprosthetic fracture (1) | NA |
Mankin et al[14] | Clin Orthop Relat Res | 15 | 52 ± 1 (16-82) | Oncologic, non-oncologic (Paget’ s disease, rheumatoid arthritis) | 54 (12-192) | 7/15 | NA | 33.3% | Prosthesis failure (4), infection (1) | NA |
Nerubay et al[26] | Clin Orthop Relat Res | 19 | 20 | Oncologic | 18-96 | 7/19 | NA | - | Wound healing problems (10), infection (1), popliteal vein injury (1), prosthesis failure (1) | NA |
Steinbrink et al[33] | J Bone Joint Surg Br | 32 (28 patients) | 56 (21-81) | Oncologic, non-oncologic (end-stage prosthetic disease, revision arthroplasty, pathologic fractures, osteoporosis) | 6-84 | 23/28 | NA | 9.4% | Infection (2), hip dislocation (1), prosthesis failure (1), patellar pain (1) | Custom |
Ward et al[34] | Clin Orthop Relat Res | 21 | 44.6 (11-91) | Oncologic, non-oncologic (revision arthroplasty, end-stage prosthetic disease) | 31 (1-125) | 11/21 | NA | 2.4% | Infection (3), hip dislocation (2), patellar pain (1) | Custom |
- Citation: Ramanathan D, Siqueira MB, Klika AK, Higuera CA, Barsoum WK, Joyce MJ. Current concepts in total femoral replacement. World J Orthop 2015; 6(11): 919-926
- URL: https://www.wjgnet.com/2218-5836/full/v6/i11/919.htm
- DOI: https://dx.doi.org/10.5312/wjo.v6.i11.919